GGrantIndex
Sort

10,766 grants matching checkpoint inhibitor

Effects of entinostat and neoantigen vaccination on bladder cancer

$46,129
Wolfgang Beckabir · Univ Of North Carolina Chapel Hill · F30 · FY2023 · CA

The role of PTEN in DNA metabolism and replication

$46,094
Abigail Rose Lubin · Icahn School Of Medicine At Mount Sinai · F31 · FY2022 · CA

Dissecting the Gut Microbiota for Immune Checkpoint Blockade (ICB) - Resisting Microbes and Exploring the Generalizability of Microbiota-ICB Studies

$46,094
Joan Shang · Icahn School Of Medicine At Mount Sinai · F30 · FY2023 · CA

Dissecting innate immune mechanisms of resistance to checkpoint blockade therapy in bladder cancer

$46,094
Michelle Alyssa Tran · Icahn School Of Medicine At Mount Sinai · F30 · FY2023 · CA

Investigating the Roles of Phospholipase A2s and Diacylglycerol Signaling in Ferroptosis

$46,060
Annie J Lin · Columbia University Health Sciences · F30 · FY2021 · CA

Identifying and Targeting Master Regulators of Drug Resistance in Lung Adenocarcinoma through Network Analysis of Tumor Transcriptomic Data

$46,060
Aaron Timothy Griffin · Columbia University Health Sciences · F30 · FY2021 · CA

Defining the Mechanism and Function of DNA Double Strand Break Induced Inhibition of V(D)J Recombination

$46,036
Rebecca Ann Glynn · University Of Pennsylvania · F31 · FY2021 · AI

Metabolically improving the generation, function, and persistence of therapeutic T cells for the treatment of cancer

$46,036
Andrew Frisch · University Of Pittsburgh At Pittsburgh · F31 · FY2021 · CA

Epigenetic regulation of myeloid regulatory cell accumulation in the tumor microenvironment

$46,036
Alyssa Merting · Augusta University · F31 · FY2021 · CA

Sensitizing Colorectal Cancer to Checkpoint Inhibitors by WNT Pathway Suppression

$46,036
Alyna Katti · Weill Medical Coll Of Cornell Univ · F31 · FY2021 · CA

T cell mechanisms of immunotherapy response in pancreatic ductal adenocarcinoma

$46,036
Emily Davis · Johns Hopkins University · F31 · FY2021 · CA

Interrogating the role of mutant KRAS allelic imbalance and co-mutated genes in targeted therapy response of NSCLC

$46,036
Bianca Diaz · Weill Medical Coll Of Cornell Univ · F31 · FY2021 · CA

Targeting Serine and Glycine Metabolic Vulnerabilities in Melanoma Brain Metastasis

$46,036
Victoria Margarita Osorio Vasquez · New York University School Of Medicine · F31 · FY2021 · CA

Regulation of inhibitory DAMP to harness immunogenic cell death

$46,036
Kazukuni Hayashi · Cedars-Sinai Medical Center · F31 · FY2021 · CA

Effect of APOBEC3 on Bladder Cancer Biology and Response to Immunotherapy

$46,036
Andrew Truong · Univ Of North Carolina Chapel Hill · F31 · FY2021 · CA

Discovering Network-Based Drivers of Single-Cell Transcriptional State in Tumor Immune Microenvironment to Reveal Immuno-Therapeutic Targets and Treatment Synergies

$46,036
Aleksandar Zoran Obradovic · Columbia University Health Sciences · F30 · FY2021 · CA

The Role of Checkpoint inhibitors in CIA

$46,036
Megan Kay Wood · Johns Hopkins University · F31 · FY2021 · AR

The Interplay Between PD-1 Blockade and T cell Development in the Context of Thymic Regeneration in Prostate Cancer

$46,036
Breanna Caruso · Oregon Health & Science University · F31 · FY2021 · CA

DNA mechanotechnology to investigate the role of PD1 biophysics in T cell signaling

$46,036
Anna Kellner · Emory University · F31 · FY2021 · CA

Rebalancing protein homeostasis enhances tumor antigen presentation

$46,036
Grissel Cervantes Jaramillo · Massachusetts Institute Of Technology · F31 · FY2021 · CA

Musculoskeletal Pain Among Breast Cancer Survivors: Through Bio-behavioral and Imaging Lenses

$46,024
Yehui Zhu · University Of Pittsburgh At Pittsburgh · F99 · FY2018 · CA

Identifying mechanisms of microbiota-dependent anti-tumor immune modulation and metabolically manipulating bacteria to improve treatment efficacy

$46,024
Jessica Lynn Fessler · University Of Chicago · F99 · FY2018 · CA

Chemical Biology of BubR1

$45,976
Joel Stuart Sandler · Rockefeller University · F32 · FY2008 · GM

FoxM1 and Oncogenic Pathways in Hepatocellular Carcinoma

$45,972
Janai R. Carr-Ascher · University Of Illinois At Chicago · F31 · FY2008 · CA

Immunology Research Program

$45,950
Jonathan Stuart Serody · Univ Of North Carolina Chapel Hill · P30 · FY2022 · CA